These 10 AI applications are poised to have the greatest impact in healthcare

Human head silhouette model made from rusty metal gears

If you have doubt that artificial intelligence is going to play a role in healthcare’s continued development, think again.

A new report from Accenture, titled “Artificial Intelligence: Healthcare’s New Nervous System,” provides a bit of clarity on why technology will be a growing force in the medical world.

Accenture predicts the health AI market will grow at an annual rate of 40 percent through 2021, reaching $6.6 billion by that year. In 2014, the market was only at $600 million.

Digging a little deeper, Accenture makes it clear that a few specific AI applications will have the biggest near-term effect on healthcare. To gain a thorough understanding of their impact, Accenture comprehensively analyzed the applications.

The organization estimates each item will have the following value (or potential annual benefits) by 2026:

  • Robot-assisted surgery — $40 billion
  • Virtual nursing assistants — $20 billion
  • Administrative workflow assistance — $18 billion
  • Fraud detection — $17 billion
  • Dosage error reduction — $16 billion
  • Connected machines — $14 billion
  • Clinical trial participant identifier — $13 billion
  • Preliminary diagnosis — $5 billion
  • Automated image diagnosis — $3 billion
  • Cybersecurity — $2 billion

In case you weren’t doing the math, this adds up to a total value of about $150 billion.

The number one application, robot-assisted surgery, specifically applies to orthopedic surgery.

“Cognitive robotics can integrate information from pre-op medical records with real-time operating metrics to physically guide and enhance the physician’s instrument precision,” the report notes. “The technology incorporates data from actual surgical experiences to inform new, improved techniques and insights.”

Accenture cited Mazor Robotics as a prime example of the value AI can bring to the operating room. Specifically, Mazor’s robotic arm allows a surgeon’s instruments to be completely guided.

By Erin Dietsche | MedCity News

Image Credit: nambitomo, Getty Images 


About Peter Coffaro 629 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.